Tingsheng Medical and GE Healthcare Forge Strategic Alliance to Advance Intracardiac Echocardiography
TINGSN
Developer of Cardiac Interventional Treatment Devices
November 6, 2024, in the morning,Jiangsu TINGSN Technology Co.,Ltd.(TINGSN) andGE Healthcare(GE Healthcare) signed in ShanghaiStrategic CooperationSign the agreement. Zhang Dongyu, Chairman of TINGSN, Wang Jing, General Manager, Wu Jian, Partner, Xu Yong, Regulatory Director, Zhang Yihao, President and CEO of GE Healthcare China, Chen Chuhui, Vice President of GE Healthcare China and General Manager of Advanced Visualization and Diagnosis & Treatment Business, Wang Lei, Vice President of GE Healthcare China and General Manager of Ultrasound Business, and Wang Jun, Director of Cardiac Ultrasound Products of GE Healthcare Ultrasound Business attended the signing ceremony.
About TINGSN
TINGSN TechnologyAs a company striving forward at the forefront of technological innovation,Demonstrates extraordinary strength and potential in the ultrasound field. TINGSN's self-developed and produced TINGSN Sonic Eyes 10, a disposable intracardiac echocardiography diagnostic catheter, obtained the NMPA registration certificate on November 28, 2023.Is an NMPA innovative medical device，which is also the first domestically developed and produced intracardiac echocardiography catheter in China. After its market launch, the product has received widespread attention and recognition in the field of cardiovascular medicine in China. Currently, it has been applied in clinical practice by more than 160 hospitals and has received unanimous praise from clinicians.
About GE Healthcare
As a giant in the global medical industry,GE HealthcareRenowned in the field of ultrasound diagnostic technology, with deep technical accumulation and extensive practical experience.Vivid iq as aGEUltrasound Flagship Portable Ultrasound Diagnostic System，InheritedGE VividWith a strong technical foundation, it has integrated more innovative echocardiography technology, featuring excellent ergonomic design, powerful cardiac clinical applications, and intelligent operational processes.So thatVivid iqIn the international medical market, it has gradually occupied an important position, providing precise diagnostic support for countless medical institutions worldwide.
Powerful Combination, Embarking on a New Journey of Ultrasound Development
The official signing of this strategic cooperation agreement is based on the profound insights and strategic planning of both parties regarding the development trends in the intracardiac echocardiography (ICE) field. TINGSN Technology and GE Healthcare will fully leverage their respective strengths to adapt TINGSN's ICE catheter with GE Healthcare’s Vivid iq ultrasound diagnostic system. This collaboration aims to rapidly expand the market share of TINGSN’s ICE catheters in China while preparing for TINGSN’s ICE entry into international markets. It also seeks to broaden and deepen the application of GE Healthcare’s Vivid iq ultrasound diagnostic system in the cardiovascular field, further solidifying its leading position in the global medical equipment market. The signing of this strategic cooperation agreement not only injects strong momentum into the development of TINGSN Technology and GE Healthcare but also sets a new benchmark for the global advancement of intracardiac echocardiography. TINGSN Technology will seize this strategic cooperation as an important opportunity to move forward hand-in-hand with GE Healthcare. Through technical complementarity and joint promotion, both parties aim to enhance their influence in the global medical field, bring more benefits to patients with heart diseases, and drive medical technology toward higher levels!